Crohn’s Disease :: Remicade receives EU approval for pediatric Crohn’s Disease

Centocor, Inc. and Schering-Plough Corporation (NYSE: SGP) announced that the European Commission has approved a new indication for REMICADE(R) (infliximab) allowing for the treatment of severe, active Crohn’s disease (CD) in pediatric patients aged 6 to 17 years, who have not responded to conventional therapy including a corticosteroid, an immunomodulator and primary nutrition therapy, or who are intolerant to, or have contraindications for, such therapies.

Aged :: Listen to the elderly, they know how they feel

Self-rated health is a strong predictor of functional decline and mortality for elderly people presenting to a hospital emergency department, according to a new study published in the latest issue of Emergency Medicine Australasia, the journal of the Australasian College for Emergency Medicine.

Rheumatoid Arthritis :: Breakthrough developments in rheumatoid arthritis reported

Peter K. Gregersen, MD, stares at x-rays of hands, searching out the telltale signs of inflamed joints and wrists from his research subjects with rheumatoid arthritis. With these clinical features at his side, he turns to the basic building blocks of life ? the human genome ? to figure out what makes these people susceptible to the disabling inflammatory condition.

Mediterranean Diet :: Can a Mediterranean diet prevent colon cancer?

Researchers at the University of Michigan Comprehensive Cancer Center are beginning a study to look at whether diet can impact a person?s risk of developing colon cancer. Specifically, the researchers will compare a Mediterranean diet ? high in olive oil, nuts and fish ? with a standard healthy eating plan.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack